61 related articles for article (PubMed ID: 19941432)
1. Mitigation of pandemic influenza: review of cost-effectiveness studies.
Lugnér AK; Postma MJ
Expert Rev Pharmacoecon Outcomes Res; 2009 Dec; 9(6):547-58. PubMed ID: 19941432
[TBL] [Abstract][Full Text] [Related]
2. Role of combination antiviral therapy in pandemic influenza and stockpiling implications.
Tsiodras S; Mooney JD; Hatzakis A
BMJ; 2007 Feb; 334(7588):293-4. PubMed ID: 17289732
[TBL] [Abstract][Full Text] [Related]
3. Cost-benefit of stockpiling drugs for influenza pandemic.
Balicer RD; Huerta M; Davidovitch N; Grotto I
Emerg Infect Dis; 2005 Aug; 11(8):1280-2. PubMed ID: 16102319
[TBL] [Abstract][Full Text] [Related]
4. Economics of employer-sponsored workplace vaccination to prevent pandemic and seasonal influenza.
Lee BY; Bailey RR; Wiringa AE; Afriyie A; Wateska AR; Smith KJ; Zimmerman RK
Vaccine; 2010 Aug; 28(37):5952-9. PubMed ID: 20620168
[TBL] [Abstract][Full Text] [Related]
5. Antiviral medications for pregnant women for pandemic and seasonal influenza: an economic computer model.
Lee BY; Bailey RR; Wiringa AE; Assi TM; Beigi RH
Obstet Gynecol; 2009 Nov; 114(5):971-980. PubMed ID: 20168096
[TBL] [Abstract][Full Text] [Related]
6. The cost effectiveness of pandemic influenza interventions: a pandemic severity based analysis.
Milne GJ; Halder N; Kelso JK
PLoS One; 2013; 8(4):e61504. PubMed ID: 23585906
[TBL] [Abstract][Full Text] [Related]
7. Effective, robust design of community mitigation for pandemic influenza: a systematic examination of proposed US guidance.
Davey VJ; Glass RJ; Min HJ; Beyeler WE; Glass LM
PLoS One; 2008 Jul; 3(7):e2606. PubMed ID: 18596963
[TBL] [Abstract][Full Text] [Related]
8. Economic analysis of pandemic influenza mitigation strategies for five pandemic severity categories.
Kelso JK; Halder N; Postma MJ; Milne GJ
BMC Public Health; 2013 Mar; 13():211. PubMed ID: 23496898
[TBL] [Abstract][Full Text] [Related]
9. Economic and social impact of influenza mitigation strategies by demographic class.
Barrett C; Bisset K; Leidig J; Marathe A; Marathe M
Epidemics; 2011 Mar; 3(1):19-31. PubMed ID: 21339828
[TBL] [Abstract][Full Text] [Related]
10. The economy-wide impact of pandemic influenza on the UK: a computable general equilibrium modelling experiment.
Smith RD; Keogh-Brown MR; Barnett T; Tait J
BMJ; 2009 Nov; 339():b4571. PubMed ID: 19926697
[TBL] [Abstract][Full Text] [Related]
11. "With human health it's a global thing": Canadian perspectives on ethics in the global governance of an influenza pandemic.
Thompson AK; Smith MJ; McDougall CW; Bensimon C; Perez DF
J Bioeth Inq; 2015 Mar; 12(1):115-27. PubMed ID: 25672615
[TBL] [Abstract][Full Text] [Related]
12. Two resource distribution strategies for dynamic mitigation of influenza pandemics.
Uribe-Sánchez A; Savachkin A
J Multidiscip Healthc; 2010 Jul; 3():65-77. PubMed ID: 21197356
[TBL] [Abstract][Full Text] [Related]
13. Lockdowned: Everyday mobility changes in response to COVID-19.
Borkowski P; Jażdżewska-Gutta M; Szmelter-Jarosz A
J Transp Geogr; 2021 Jan; 90():102906. PubMed ID: 35721765
[TBL] [Abstract][Full Text] [Related]
14. A Bayes Decision Rule to Assist Policymakers during a Pandemic.
Cao KH; Damien P; Woo CK; Zarnikau J
Healthcare (Basel); 2021 Aug; 9(8):. PubMed ID: 34442160
[TBL] [Abstract][Full Text] [Related]
15. Cost-effectiveness of emergency preparedness measures in response to infectious respiratory disease outbreaks: a systematic review and econometric analysis.
Vardavas C; Nikitara K; Zisis K; Athanasakis K; Phalkey R; Leonardi-Bee J; Johnson H; Tsolova S; Ciotti M; Suk JE
BMJ Open; 2021 Apr; 11(4):e045113. PubMed ID: 33926982
[TBL] [Abstract][Full Text] [Related]
16. Investigating duration and intensity of Covid-19 social-distancing strategies.
Neuwirth C; Gruber C; Murphy T
Sci Rep; 2020 Nov; 10(1):20042. PubMed ID: 33208759
[TBL] [Abstract][Full Text] [Related]
17. Cost-utility analysis of antiviral use under pandemic influenza using a novel approach - linking pharmacology, epidemiology and heath economics.
Wu DBC; Chaiyakunapruk N; Pratoomsoot C; Lee KKC; Chong HY; Nelson RE; Smith PF; Kirkpatrick CM; Kamal MA; Nieforth K; Dall G; Toovey S; Kong DCM; Kamauu A; Rayner CR
Epidemiol Infect; 2018 Mar; 146(4):496-507. PubMed ID: 29446343
[TBL] [Abstract][Full Text] [Related]
18. Buy now, saved later? The critical impact of time-to-pandemic uncertainty on pandemic cost-effectiveness analyses.
Drake T; Chalabi Z; Coker R
Health Policy Plan; 2015 Feb; 30(1):100-10. PubMed ID: 24369125
[TBL] [Abstract][Full Text] [Related]
19. Identifying the relative priorities of subpopulations for containing infectious disease spread.
Xia S; Liu J; Cheung W
PLoS One; 2013; 8(6):e65271. PubMed ID: 23776461
[TBL] [Abstract][Full Text] [Related]
20. Cost-effectiveness analysis of pandemic influenza preparedness: what's missing?
Drake TL; Chalabi Z; Coker R
Bull World Health Organ; 2012 Dec; 90(12):940-1. PubMed ID: 23284200
[No Abstract] [Full Text] [Related]
[Next] [New Search]
